![]() |
![]() |
![]() |
![]() |
| Preventing HIV |
| Treating HIV |
| Living with HIV |
| For service providers |
| For health care providers |
| Access our services |
| Find organizations |
| News and events |
| About CATIE |
| Site map |
| Home |
| CATIE Ordering Centre |
Fact Sheets Pneumocystis pneumonia (PCP) SummaryPneumocystis pneumonia (PCP) is a type of pneumonia that can be life-threatening in people with weakened immune systems. People living with HIV whose CD4 counts are below 200 are at risk of developing PCP. The symptoms can include fever, shortness of breath, tightness or pain in the chest, fatigue, night sweats and a dry cough. Fortunately, there are medications that can effectively prevent and treat the illness. Today, PCP is relatively rare; however, it remains common among people who do not know they have HIV, people who are not receiving ongoing HIV care, and people with severely weakened immune systems. What is PCP?PCP is a type of pneumonia caused by a fungus called Pneumocystis jiroveci. This fungus does not make people with healthy immune systems sick but can cause a lung infection in a person who has a weakened immune system. PCP is one of a number of infections that can develop in people who are living with HIV, called opportunistic infections. These occur only if your immune system is quite weakened and your body becomes vulnerable to infections that would not otherwise affect you. PCP is the most common opportunistic infection among people living with HIV. Pneumonia is an infection and inflammation of the lungs. As the infection progresses, the air spaces in the lungs fill with fluid, making it more and more difficult to breathe. Who is at risk for PCP?People who have a weakened immune system, due to HIV, cancer, long-term use of corticosteroid drugs or an organ or bone marrow transplant, are at risk of developing PCP. People with HIV most at risk of developing PCP are those who:
SymptomsThe symptoms of PCP can include:
In people living with HIV, these symptoms may develop very gradually. At first, the symptoms may be so mild that they go unnoticed for several weeks. Because PCP can be so dangerous if not treated early, if you experience symptoms of PCP, such as a persistent dry cough or shortness of breath, it is important that you report them to a doctor as soon as possible. DiagnosisThe symptoms of PCP are common to many infections, including the flu and common cold, so lab tests must be done to confirm the diagnosis. Your doctor may order one or more of the following tests:
If PCP is diagnosed, two other tests may be performed to find out how serious the pneumonia is:
The results of these tests can help your doctor classify the PCP as mild, moderate or severe; choose the most suitable treatment; and determine whether medication can be taken at home or in hospital. TreatmentIf you are diagnosed with an acute case of PCP and are not already taking anti-HIV drugs, it is recommended that you start, regardless of your CD4 count. This should strengthen your immune system and help you fight off the infection. Your doctor may suggest you start taking anti-HIV drugs after your anti-PCP treatment is complete or two weeks after starting anti-PCP treatment. The most effective medication for treating PCP is a powerful combination of antibiotics called TMP/SMX (commonly sold under the brand names Septra or Bactrim). It contains two antibiotics: trimethoprim (TMP) and sulfamethoxazole (SMX). For most people with mild to moderate cases of PCP, taking this treatment orally, on an outpatient basis (at home), is very effective. For people with moderate to severe cases of PCP, corticosteroid drugs are often prescribed in addition to TMP/SMX. Although long-term use of corticosteroids can weaken the immune system, short-term use can help to reduce inflammation and damage to the lungs. Corticosteroids should be started as soon as possible—within 72 hours of starting TMP/SMX. People with severe PCP and other conditions that make it difficult to swallow medications may need to take the antibiotics intravenously (by IV) in the hospital. (TMP/SMX also protects against another opportunistic infection called toxoplasmosis.) You may also be given oxygen to inhale through a mask, as part of your treatment. Treatment for PCP usually lasts 21 days. The way you respond to the treatment depends on the drugs used, whether or not you have had previous episodes of PCP, the severity of the illness, the state of your immune system, and when the treatment started. Your doctor should monitor your treatment carefully. Common side effects from TMP/SMX include a rash, fever, nausea, vomiting, loss of appetite, low white blood cell count and low platelet count. Your doctor may recommend additional medications to manage these side effects. Many HIV-positive people are allergic or hypersensitive to this medication. In these cases, alternative medications can be prescribed. There is evidence to suggest that in some cases where people are hypersensitive to TMP/SMX, starting with a small amount of TMP/SMX and increasing the amount until a full dose can be tolerated can help a person overcome adverse reactions, or help “desensitize” a person who is hypersensitive to the medication. When taken by pregnant women, TMP/SMX may increase the risk of birth defects. Folic acid supplements may reduce this risk. Because a woman with PCP also faces a higher risk of preterm labour and delivery, pregnant women who have PCP after 20 weeks of pregnancy should be monitored for early contractions. If, after four to eight days of anti-PCP treatment, the pneumonia has shown no sign of improvement or has worsened, your doctor may recommend another treatment. Other anti-PCP treatments, such as dapsone and TMP, primaquine and clindamycin, or atovaquone, offer alternatives to people who cannot tolerate TMP/SMX. Once the pneumonia has cleared up, your doctor may recommend that you take medication to prevent the infection from coming back. This preventive medication should be taken until your CD4 count stays above 200 for at least three consecutive months. Talk to your doctor before you start or stop taking any prescribed medications. PreventionThe best way to prevent PCP is to keep your immune system strong and your CD4 count well above 200. Taking anti-HIV drugs can help keep your CD4 count above 200. If you smoke, another way you can help reduce the risk of getting PCP is to quit smoking. Research has shown that smokers living with HIV are far more likely to develop PCP than non-smokers living with HIV. Preventive medication should be taken by HIV-positive adults and adolescents, including pregnant women and people on anti-HIV drugs, whose CD4 count is below 200 or have a history of thrush. The medication used to treat PCP can also be taken to prevent it. The most effective preventive medication is TMP/SMX; for more information, see the Treatment section. | |
|
2010 Author(s): Koenig D | |
|
|
|
Decisions about particular medical treatments should always be made in consultation with a qualified medical practitioner who is knowledgeable about HIV-related illness and the treatments in question. MORE | |